HRTX - HERON THERAPEUTICS, INC. /DE/

QQQ $ 601.92 $ -5.20 (-0.85 %)

DIA $ 465.85 $ -5.48 (-1.16 %)

SPY $ 664.42 $ -6.26 (-0.93 %)

TLT $ 89.13 $ 0.22 (0.25 %)

GLD $ 370.71 $ -4.31 (-1.15 %)

Previous Close

$ 1.09

Open

$ 1.12

Bid

$ 1.08 x 502

Ask

$ 1.09 x 4,031

Day's Range

$ 1.07 - $ 1.13

52 Week Range

$ 1.05 - $ 2.68

Volume

1,346,113

Average Volume

Market Cap

199.87M

Beta (5Y Monthly)

$ 1.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-08-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-27-2025	01-01-1970	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	03-12-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-14-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-29-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-10-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-05-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	03-02-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-05-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	02-22-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	02-27-2018	12-31-2017	10-K
33	11-06-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	02-23-2017	12-31-2016	10-K
37	11-08-2016	09-30-2016	10-Q
38	08-08-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	02-19-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UPDATE: Heron Therapeutics Q3 Adj. EPS $(0...
11/04/2025 14:37:40

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of ...

Heron Therapeutics Affirms FY2025 Sales Gu...
11/04/2025 13:03:17

Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.000 million-$163.000 million to $153.000 million-$163.0...

Heron Therapeutics Q3 EPS $(0.10) Misses $...
11/04/2025 13:02:40

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of ...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Heron Therapeutics Files For Mixed Shelf O...
09/09/2025 21:15:16

-SEC Filing

Heron Therapeutics Adopts Section 382 Righ...
08/15/2025 11:47:15

Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, to...

Needham Maintains Buy on Heron Therapeutic...
08/08/2025 19:01:51

Needham analyst Serge Belanger maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and lowers the price target from $4 to $3.

12 Health Care Stocks Moving In Friday's I...
08/08/2025 17:07:58

Heron Therapeutics Affirms FY2025 Sales Gu...
08/08/2025 11:57:41

Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.000 million-$163.000 million to $153.000 million-$163.0...

Heron Therapeutics Q2 EPS $(0.02) Misses $...
08/08/2025 11:53:55

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of ...

this-ryder-system-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This Ryder System Analyst Begins Coverage ...
06/09/2025 15:23:37

HC Wainwright & Co. Initiates Coverage On ...
06/09/2025 11:29:16

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Heron Therapeutics (NASDAQ:HRTX) with a Buy rating and ...

Heron Therapeutics Affirms FY2025 Sales Gu...
05/06/2025 12:09:22

Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.00 million-$163.00 million to $153.00 million-$163.00 m...

Heron Therapeutics Q1 EPS $0.01 Beats $(0....
05/06/2025 12:03:31

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(...

Heron Therapeutics Enters Settlement Agree...
05/06/2025 11:32:59

Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

Needham Reiterates Buy on Heron Therapeuti...
04/11/2025 10:46:52

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $4 price target.

Needham Reiterates Buy on Heron Therapeuti...
02/28/2025 10:14:59

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $4 price target.

Heron Therapeutics Expects 2025 Sales Of $...
02/27/2025 12:48:45

Financial Guidance for 2025 Item2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA(in millions) Net Revenue$153.0 to$1...

Heron Therapeutics Q4 2024 GAAP EPS $0.02 ...
02/27/2025 12:46:24

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(...